(Press-News.org) The majority of family doctors receive little or no information about harmful effects of medicines when visited by drug company representatives, according to an international study involving Canadian, U.S. and French physicians.
Yet the same doctors indicated that they were likely to start prescribing these drugs, consistent with previous research that shows prescribing behaviour is influenced by pharmaceutical promotion.
The study, which had doctors fill out questionnaires about each promoted medicine following sales visits, was published online today in the Journal of General Internal Medicine. It shows that sales representatives failed to provide any information about common or serious side effects and the type of patients who should not use the medicine in 59 per cent of the promotions. In Vancouver and Montreal, no potential harms were mentioned for 66 per cent of promoted medicines.
"Laws in all three countries require sales representatives to provide information on harm as well as benefits," says lead author Barbara Mintzes of the University of British Columbia. "But no one is monitoring these visits and there are next to no sanctions for misleading or inaccurate promotion."
Serious risks were mentioned in only six percent of the promotions, even though 57 per cent of the medications involved in these visits came with US Food and Drug Administration "black box" or Health Canada boxed warnings – the strongest drug warning that can be issued by both countries.
"We are very concerned that doctors and patients are left in the dark and patient safety may be compromised," says Mintzes, an expert on drug advertising in UBC's School of Population and Public Health.
Doctors in Toulouse were more likely to be told of a harmful effect in a promotional visit, compared to doctors in Canada and the U.S., according to the study. Researchers suggested that this may reflect stricter regulatory standards for promotion of medicines in France.
NB: Figures showing the study's key findings are available at
https://www.dropbox.com/sh/gzo3d9uqy19rexl/ULFOzdk5d-.
###
BACKGROUND | DRUG SALES VISITS LACK DETAILS
About the study
The UBC-led study is the most comprehensive to date of the quality of pharmaceutical sales representative promotions to family physicians.
Researchers recruited physicians to participate using random samples from lists of primary care physicians at four sites – Vancouver, Montreal, Sacramento and Toulouse. Among 704 eligible physicians contacted, 255 (36 per cent) chose to participate. Information was collected on 1,692 drug promotions at sales visits between May 2009 to June 2010.
Doctors were asked to fill out a questionnaire about the information provided for each promoted medicine following each visit they received from pharmaceutical sales representatives. Sales representatives regularly visit doctors' offices to promote medicines by providing information, free samples and in some cases food and invitations to events. The study focused on how often information was provided about drug safety.
The team includes researchers from UBC, York University, University of Montreal, University of California, Davis and the University of Toulouse.
Third-party comment
Dr. Tom Perry, an internal medicine and clinical pharmacology specialist at the UBC Hospital in Vancouver, who is not part of the study, expressed concern about the findings:
"Doctors learn relatively little about drugs in medical school, and much of their exposure to pharmacology after graduation may be in the form of advertising. If they are unaware of the potential harms from drugs they prescribe, patients inevitably suffer the consequences."
Perry also called for much stricter control of drug advertising in Canada.
Dr. Perry can be reached by pager 604-707-1427 or e-mail tperryjr@shaw.ca.
CONTACT
Prof. Barbara Mintzes
UBC School of Population and Public Health
Heather Amos
UBC Public Affairs
Tel: 604-822-3213
Cell: 604-828-3867
E-mail: heather.amos@ubc.ca END
Doctors not informed of harmful effects of medicines during sales visits
2013-04-10
ELSE PRESS RELEASES FROM THIS DATE:
Scripps Research Institute scientists help unravel central mystery of Alzheimer's disease
2013-04-10
LA JOLLA, CA – April 10, 2013 – Scientists at The Scripps Research Institute (TSRI) have shed light on one of the major toxic mechanisms of Alzheimer's disease. The discoveries could lead to a much better understanding of the Alzheimer's process and how to prevent it.
The findings, reported in the April 10, 2013 issue of the journal Neuron, show that brain damage in Alzheimer's disease is linked to the overactivation of an enzyme called AMPK. When the scientists blocked this enzyme in mouse models of the disease, neurons were protected from loss of synapses—neuron-to-neuron ...
AACR news: Studies show increasing evidence that androgen drives breast cancer
2013-04-10
Estrogen and progesterone receptors, and the gene HER2 – these are the big three markers and/or targets in breast cancer. Evidence presented at the AACR Annual Meeting 2013 adds a fourth: androgen receptors.
"This is a continuing line of work with all evidence pointing toward the addition of the androgen receptor as potential target and useful marker in all of the major subtypes of breast cancer," says Jennifer Richer, PhD, investigator at the University of Colorado Cancer Center and co-director of the CU Cancer Center Tissue Processing and Procurement Core.
The finding ...
A ghostly green bubble
2013-04-10
Stars the size of the Sun end their lives as tiny and faint white dwarf stars. But as they make the final transition into retirement their atmospheres are blown away into space. For a few tens of thousands of years they are surrounded by the spectacular and colourful glowing clouds of ionised gas known as planetary nebulae.
This new image from the VLT shows the planetary nebula IC 1295, which lies in the constellation of Scutum (The Shield). It has the unusual feature of being surrounded by multiple shells that make it resemble a micro-organism seen under a microscope, ...
The adult generations of today are less healthy than their counterparts of previous generations
2013-04-10
Sophia Antipolis, 10 April 2013. Despite their greater life expectancy, the adults of today are less "metabolically" healthy than their counterparts of previous generations. That's the conclusion of a large cohort study from the Netherlands which compared generational shifts in a range of well established metabolic risk factors for cardiovascular disease. Assessing the trends, the investigators concluded that "the more recently born generations are doing worse", and warn "that the prevalence of metabolic risk factors and the lifelong exposure to them have increased and ...
Limiting greenhouse gas emissions from land use in Europe
2013-04-10
EGU Press Conference, Wednesday, 10 April-- Not only do humans emit greenhouse gases into the atmosphere, but they also do things that help remove these gases from the atmosphere—for example, planting more forests or other land management techniques can lead to greater uptake of greenhouse gases from the atmosphere. New research presented by IIASA researcher Hannes Böttcher at the EGU General Assembly this week estimates future land use emissions for the European Union. These scenarios provide the basis for policy discussions in the EU, and also help identify the least ...
Reliability of neuroscience research questioned
2013-04-10
New research has questioned the reliability of neuroscience studies, saying that conclusions could be misleading due to small sample sizes.
A team led by academics from the University of Bristol reviewed 48 articles on neuroscience meta-analysis which were published in 2011 and concluded that most had an average power of around 20 per cent – a finding which means the chance of the average study discovering the effect being investigated is only one in five.
The paper, being published in Nature Reviews Neuroscience today [10 April], reveals that small, low-powered studies ...
Botanists in the rainforest
2013-04-10
This press release is available in German.
Fruit-eating animals are known to use their spatial memory to relocate fruit, yet, it is unclear how they manage to find fruit in the first place. Researchers of the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany, have now investigated which strategies chimpanzees in the Taï National Park in Côte d'Ivoire, West Africa, use in order to find fruit in the rain forest. The result: Chimpanzees know that trees of certain species produce fruit simultaneously and use this botanical knowledge during their daily ...
Ludwig presents advancements in immunotherapy and epigenetics at the American Association for Cancer Research Annual Meeting
2013-04-10
April 10, 2013, New York, NY – A dozen Ludwig scientists from around the world presented the latest advancements in basic and clinical cancer research at this week's American Association for Cancer Research (AACR) Annual Meeting 2013. Progress in immunotherapy and epigenetics led the program with important diagnostic and treatment implications for emerging cancer therapy.
"With new immunotherapy agents available to help patients with melanoma, researchers are developing prognostic biomarkers to determine who will benefit most to fully realize the potential of these ...
World-first research will save koalas
2013-04-10
The "holy grail" for understanding how and why koalas respond to infectious diseases has been uncovered in an Australian-led, world-first genome mapping project.
The joint undertaking between QUT (Queensland University of Technology in Brisbane, Australia) and The Australian Museum has unearthed a wealth of data, including the koala interferon gamma (IFN-g) gene - a chemical messenger that plays a key role in the iconic marsupial's defence against cancer, viruses and intracellular bacteria.
Professor Peter Timms, from QUT's Institue of Health and Biomedical Innovation ...
Fighting disease from within the mosquito: New techniques to help halt the spread of disease
2013-04-10
Scientists have revealed a new technique to introduce disease-blocking bacteria into mosquitoes, with promising results that may halt the spread of diseases such as dengue, yellow fever and potentially malaria.
When infected with the bacteria Wolbachia, mosquitoes are unable to spread viruses such as dengue, a disease which kills round 40,000 people each year with no vaccines or specific treatments currently available. There have been around 2,400 cases of dengue infection in Northern Australia in recent years.
However, the bacteria has been difficult to spread within ...